Valuation: BICO Group AB

Market Cap 1.12B 110M 100M 92.95M 84.08M 158M 10.29B 165M 446M 5.56B 413M 405M 17.62B P/E 2026 *
-2.88x
P/E 2027 * -8.04x
Enterprise Value 1.12B 110M 99.79M 92.37M 83.55M 157M 10.23B 164M 443M 5.53B 411M 402M 17.51B EV / Sales 2026 *
0.71x
EV / Sales 2027 * 0.67x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day-2.94%
1 week-5.01%
Current month-34.89%
1 month-34.35%
3 months-4.56%
6 months-10.36%
Current year-24.41%
1 week 15.08
Extreme 15.08
17.3
1 month 15.08
Extreme 15.08
25.4
Current year 12.94
Extreme 12.94
25.4
1 year 12.94
Extreme 12.94
25.4
3 years 12.94
Extreme 12.94
72.3
5 years 12.94
Extreme 12.94
327.8
10 years 12.94
Extreme 12.94
630
Manager TitleAgeSince
Chief Executive Officer 51 2026-08-31
Director of Finance/CFO 56 2026-02-28
Chief Operating Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 71 2019-12-17
Director/Board Member 37 2015-02-28
Director/Board Member 51 2026-05-06
Date Insider Type Main position Quantity % Market Cap. Importance
8/21/26 Buy

Director

15,000 0.0217%
4/30/26 Buy

Director

25,000 0.0362%
4/30/26 Buy

Chief Operating Officer

10,000 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%-5.01%-15.00%-67.28% 113M
-0.58%-4.04%+19.57%+47.67% 257B
-0.45%-3.29%+0.91%+9.52% 161B
-3.26%-9.41%-25.52%+33.40% 146B
-1.49%-4.74%-56.67%-20.89% 63.26B
-1.28%-1.82%+23.61%+55.28% 60.51B
-0.05%+0.69%+5.41%-12.43% 53.46B
-1.12%-0.91%+21.90%+54.96% 49.99B
-5.15%-13.73%-3.95%+48.93% 44.88B
-2.06%-3.06%+21.20%+74.31% 45.81B
Average -1.85%-3.33%-0.85%+22.35% 88B
Weighted average by Cap. -1.42%-3.95%+1.66%+32.15%

Financials

2026 *2027 *
Net sales 1.58B 155M 141M 131M 118M 222M 14.48B 232M 627M 7.82B 582M 569M 24.78B 1.58B 155M 141M 131M 118M 222M 14.46B 232M 626M 7.82B 581M 569M 24.76B
Net income -390M -38.29M -34.89M -32.29M -29.21M -54.8M -3.58B -57.35M -155M -1.93B -144M -141M -6.12B -95.3M -9.35M -8.52M -7.88M -7.13M -13.38M -873M -14M -37.8M -472M -35.07M -34.34M -1.49B
Net Debt -7M -687K -626K -579K -524K -983K -64.13M -1.03M -2.78M -34.65M -2.58M -2.52M -110M -72M -7.06M -6.43M -5.96M -5.39M -10.11M -660M -10.58M -28.56M -356M -26.5M -25.94M -1.13B
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
512
Date Price Change Volume
26-11-19 SEK 15.92 -2.33% 501,471
26-11-18 SEK 16.30 +4.62% 474,612
26-11-17 SEK 15.58 0.00% 920,177
26-11-16 SEK 15.58 -6.71% 1,460,691
26-11-13 SEK 16.70 +0.36% 653,590
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BICO Group AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.92SEK
Average target price
31.50SEK
Spread / Average Target
+97.86%
  1. Stock Market
  2. Stocks
  3. BICO Stock